412
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product

, , , &
Pages 168-172 | Received 29 Sep 2015, Accepted 05 Nov 2015, Published online: 10 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yuanyuan Zhang, Zewen Li, Hui Tang, Wenjie Ren, Xin Gao, Yangjian Sun, Qiu Xiang Zhao, Fanye Wang & Junhong Liu. (2020) Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology. Drug Development and Industrial Pharmacy 46:1, pages 42-49.
Read now
Simay Yıldız, Eren Aytekin, Burçin Yavuz, Sibel Bozdağ Pehlivan, İmran Vural & Nurşen Ünlü. (2018) Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules. Pharmaceutical Development and Technology 23:5, pages 488-495.
Read now

Articles from other publishers (1)

Akula Ramesh, Jagadish Purale Channabasavaish, Vinay Jhawar, Proneel Das, Prajakta Patil & Srinivas Mutalik. (2022) Maraviroc Oral Disintegration Tablet: Analytical Design of Experiments (DoE) for Assessment and Comparison of In vitro Dissolution Profiles . Current Pharmaceutical Analysis 18:4, pages 427-436.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.